Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Success depends on reasonable expectations, appropriate medical supervision, and persistent treatment
These studies have consistently demonstrated the positive impact of Semaglutide on reducing body weight and improving glycemic control
For administration, a 1mL U-100 insulin syringe is the standard for precise dosing
6.8% on placebo in STEP 1 Most common timing / during the first 8 to 20 weeks of dose escalation Discontinuation rate due to GI events / approximately 4.5% in key trials Mechanism / delayed gastric emptying plus direct brainstem GLP-1 receptor activation Red-flag sign / inability to keep fluids down for more than 24 hours Emergency sign / hematemesis (bloody vomit), severe epigastric pain, or signs of pancreatitis Dose modification / your prescriber may hold or reduce the dose rather than discontinue Dehydration risk / higher in patients also taking SGLT2 inhibitors or diuretics Why Wegovy Causes Vomiting Semaglutide 2.4 mg triggers vomiting through two overlapping pathways: slowed gastric motility and direct central nervous system signaling
US$ 23.23
US$ 21.15
US$ 28.14
US$ 28.56
US$ 24.63
US$ 27.81
